DaVita
Prix: 208.66Entreprise et modèle économique
DaVita Inc. operates in the healthcare sector, primarily providing kidney care and dialysis services. The company offers a range of services including in-center hemodialysis, home dialysis, and related laboratory services. Its major business segments include dialysis services and ancillary services, with the majority of revenue generated from patient services in its dialysis centers. DaVita serves a diverse patient population across the United States and has a growing presence in international markets.
Profil d’investissement
The investment profile of DaVita is more aligned with growth investors, given its focus on expanding services and improving patient care. The company has shown potential for revenue growth despite recent fluctuations. It may appeal to investors looking for a balanced approach, considering its operational stability and market position.
Métriques fondamentales (expérimental)
- BPA (TTM) — bénéfice par action des 12 derniers mois, $
- 10.15 OK
- Chiffre d’affaires QoQ — croissance trimestrielle du chiffre d’affaires
- -5.6% ↓
- Surprise BPA
- 23.2% meilleur que prévu
- Volatilité 20 j
- 1.9% stable
Suivre dans le portefeuille
Graphique des prix
| Date | Avant | Après | Raison |
|---|---|---|---|
| 2026-06-10 00:47 | Conserver | Acheter | Strong momentum and positive EPS surprise support growth outlook. |
| 2026-06-01 02:36 | Acheter | Conserver | Strong momentum but recent revenue decline raises concerns. |
| 2026-05-16 02:40 | Conserver | Acheter | Strong momentum and positive EPS surprise support bullish outlook. |
| Date | Analyste | Action | Objectif | Prix alors |
|---|---|---|---|---|
| 2026-05-08 11:56 | Truist Financial | Objectif relevé | 158 → 205 | 194.385 |
| 2026-05-07 09:46 | Barclays | Objectif relevé | 158 → 194 | 193.88 |
| 2026-05-06 08:37 | Deutsche Bank | Note relevée | — → 220 | 157.04 |
Rien pour le moment